Immunic Inc (NASDAQ:IMUX)
| 1.20 Delayed Data As of Dec 08 |  +0.045 / +3.91%Today’s Change | 1.13 Today|||52-Week Range 14.50 | -87.51% Year-to-Date |
Latest IMUX News | Press Releases
No recent news for Immunic Inc.
Today’s Trading
| Previous close | 1.15 |
| Today’s open | 1.17 |
| Day’s range | 1.15 - 1.23 |
| Volume | 11,613 |
| Average volume (3 months) | 2,714,737 |
| Market cap | $53.0M |
Data as of 2:32pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | -39.84% |
| Earnings growth (this year) | +25.45% |
| Earnings growth (next 5 years) | +15.51% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRVSCorvus Pharmaceutica... | -0.04 | -3.81% |
| HOOKHOOKIPA Pharma Inc | -0.04 | -3.95% |
| TCRRTCR2 Therapeutics In... | -0.08 | -6.35% |
| AQSTAquestive Therapeuti... | +0.03 | +3.35% |
Data as of 3:15pm ET, 12/08/2022
Financials
| Next reporting date | February 24, 2023 |
| EPS forecast (this quarter) | -$0.75 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$92.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
